{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:54:13Z","timestamp":1791557653473,"version":"4.3.4"},"reference-count":22,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Pruritus in primary biliary cholangitis (PBC) worsens patients' health\u2010related quality of life (HRQoL). Serum alkaline phosphatase (ALP), a biomarker of PBC activity, has an unclear relationship with pruritus severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, cross\u2010sectional analysis utilized data from participants with confirmed PBC diagnoses, from the PicnicHealth PBC registry, with \u2265\u20091 completed PBC\u201040 questionnaire (most recent was used). The primary analysis included participants with a qualifying ALP measurement. Participants were categorized by pruritus severity per PBC\u201040 itch domain (clinically significant [CS] pruritus [score \u2265\u20097], or non\u2010CS pruritus [score\u2009=\u20091\u20136]); serum ALP (normal [ALP \u2264\u20091 \u00d7 upper limit of normal; ULN], mildly elevated [ALP &gt;\u20091\u2013&lt;\u20091.67 \u00d7 ULN], or high [ALP \u2265\u20091.67 \u00d7 ULN]; primary analysis). Primary outcome: proportion of participants in each pruritus severity subgroup by ALP category. Secondary outcome (all participants with PBC\u201040): HRQoL by pruritus severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 232 participants completed \u2265\u20091 PBC\u201040 questionnaire; 141 had a qualifying ALP measurement. Most participants with pruritus were female (97%) and white (93%); 53% had CS pruritus. 23% (13\/57), 32% (17\/53) and 52% (16\/31) of participants with normal, mildly elevated and high ALP, respectively, reported CS pruritus. Participants with CS pruritus had significantly higher scores across non\u2010itch PBC\u201040 domains (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) versus non\u2010CS pruritus and greater odds of having CS PBC\u201040 domain scores versus no CS pruritus (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001; odds ratio [95% CI]: Symptoms 7.08 [3.89, 12.90]; Fatigue 9.51 [4.71, 19.22]; Emotional 2.67 [1.50, 4.76]; Social 6.14 [3.47, 10.88]; Cognitive 4.03 [2.33, 6.96]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CS pruritus is common, present in patients irrespective of ALP levels and significantly impacts HRQoL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/liv.70809","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:29:11Z","timestamp":1788942551000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unravelling the Itch: Cross\u2010Sectional Analysis of Pruritus Patterns in the\n                    <scp>PicnicHealth<\/scp>\n                    Primary Biliary Cholangitis Registry"],"prefix":"10.1111","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-6037","authenticated-orcid":false,"given":"Cynthia","family":"Levy","sequence":"first","affiliation":[{"name":"Digestive Health and Liver Diseases, Miller School of Medicine University of Miami  Miami Florida USA"},{"name":"Schiff Center for Liver Diseases University of Miami  Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-9535","authenticated-orcid":false,"given":"Daniel C.","family":"Gibbons","sequence":"additional","affiliation":[{"name":"GSK  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Abner","sequence":"additional","affiliation":[{"name":"PicnicHealth  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley S.","family":"Friedler","sequence":"additional","affiliation":[{"name":"PicnicHealth  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9562-7811","authenticated-orcid":false,"given":"Dhirishiya","family":"P","sequence":"additional","affiliation":[{"name":"GSK  Bangalore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-0903","authenticated-orcid":false,"given":"Harini","family":"Vadlamudi","sequence":"additional","affiliation":[{"name":"GSK  Bangalore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Earley\u2010Valovic","sequence":"additional","affiliation":[{"name":"GSK  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Coutinho","sequence":"additional","affiliation":[{"name":"GSK  Collegeville Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Hagan","sequence":"additional","affiliation":[{"name":"GSK  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejsi","family":"Begaj","sequence":"additional","affiliation":[{"name":"GSK  Collegeville Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Halliday","sequence":"additional","affiliation":[{"name":"GSK  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.007"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07581-x"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2023-001287"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00134-4"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.065862"},{"key":"e_1_2_12_7_1","article-title":"Assessing the Health\u2010Related Quality of Life, Impairment and Productivity Among Individuals With PBC and Pruritus: Results From the ITCH\u2010E Study","volume":"80","author":"Levy C.","year":"2024","journal-title":"Hepatology"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20276"},{"key":"e_1_2_12_9_1","article-title":"Pervasive Role of Pruritus in Impaired Quality of Life in Patients With Primary Biliary Cholangitis: Data From the GLIMMER Study","volume":"9","author":"Smith H.","year":"2025","journal-title":"Hepatology Communications"},{"key":"e_1_2_12_10_1","volume-title":"Sleep Disturbance Due to Pruritus is Associated With Anxiety, Depression, and Worse Quality of Life: Evidence for Management of Pruritus and Sleep in Chronic Liver Disease","author":"Bonder A.","year":"2024"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30145"},{"key":"e_1_2_12_12_1","volume-title":"Insufficient Control of Cholestatic Pruritus in Primary Biliary Cholangitis (PBC) With Current Therapies: Baseline Data From the Ongoing Phase 3 GLISTEN (Global Linerixibat Itch Study of Efficacy And Safety in PBC) Trial","author":"Hirschfield G. M.","year":"2024"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.005"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.12.012"},{"key":"e_1_2_12_15_1","unstructured":"R.Porter A.Diehl B.Pastel et\u00a0al. \u201cLLMD: A Large Language Model for Interpreting Longitudinal Medical Records \u201d(2024) arXiv Preprint arXiv:241012860."},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26365"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2560"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S134864"},{"key":"e_1_2_12_19_1","volume-title":"Identifying Drivers of Patient Preference in the Treatment of Pruritus in Primary Biliary Cholangitis (PBC)","author":"Halliday A.","year":"2023"},{"key":"e_1_2_12_20_1","volume-title":"Patient\u2010Reported Indicators of Health and Symptoms in US Patients With Primary Biliary Cholangitis (PBC)","author":"Carey E. J.","year":"2018"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03798-x"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26909"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/liv.70809","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:40:37Z","timestamp":1791556837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.70809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/liv.70809"],"URL":"https:\/\/doi.org\/10.1111\/liv.70809","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"2025-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70809"}}